The pilot uses HP technology to “print” pharmaceutical samples rather than ink. For the first time, regional labs can conduct rapid susceptibility testing for health departments and hospitals across the U.S.
“This pilot project will help ensure healthcare providers have the latest information to inform their prescribing, the newest drugs last longer, and gold-standard lab results are in healthcare providers’ hands faster,” the CDC said.
CDC and HP will assess the pilot in the four regional laboratories, refine the system and explore a larger rollout of inkjet printing technology in labs nationwide.
The project’s initial results are expected by early 2019.
More articles on clinical leadership and infection control:
Paper-based test can effectively identify ‘falsified’ antibiotics
Patients in private rooms less likely to get fatal hospital infection, study finds
CDC hosts infectious disease experts to discuss HAIs, Ebola
